Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Sarcoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hodgkin Disease 1 Histiocytoma, Angiomatoid Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Granuloma, Plasma Cell 1 Granular Cell Tumor 1 Glomus Tumor 1 Glioma 1 Glioblastoma 1 Fibrosarcoma 1

Interventions

pembrolizumab 14 Paclitaxel 13 Carboplatin 12 Bevacizumab 7 Specimen Handling 6 Cisplatin 6 olaparib 5 Taxes 5 Fulvestrant 5 Nivolumab 4 Megestrol Acetate 4 Magnetic Resonance Spectroscopy 4 Biopsy 4 palbociclib 3 durvalumab 3 Oxaliplatin 3 Leucovorin 3 Letrozole 3 Immunoglobulin G 3 Fluorouracil 3 Doxorubicin 3 Docetaxel 3 Disulfides 3 trastuzumab deruxtecan 2 ribociclib 2 pertuzumab 2 lenvatinib 2 ipatasertib 2 dostarlimab 2 capivasertib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × selinexor × 30 days × Clear all

NCT05611931 2026-05-29

XPORT-EC-042

Karyopharm Therapeutics Inc

Phase 3 Active not recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡